Hidden Costs Of Arthritis Treatment Include Liver Damage, Medical Bills, And Serious Impacts Highlight Role of SSDI Benefits, Allsup Reports
August 29, 2023 14:30 ET
|
Allsup
Belleville, Illinois, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Recent research on the effects of rheumatoid arthritis treatment highlights the challenges of treating chronic health conditions and the...
Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis
July 26, 2023 07:30 ET
|
Incannex Healthcare
MELBOURNE, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique...
Canes and Crutches Market is expected to generate USD 1.39 Billion in Revenues by 2031 with CAGR of 3.4%: Report from TMR
July 24, 2023 13:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, July 24, 2023 (GLOBE NEWSWIRE) -- The global canes and crutches market was worth US$ 957.4 million in 2022. The global canes and crutches market is predicted to...
Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis
July 13, 2023 08:00 ET
|
Incannex Healthcare
Highlights: Incannex has received approval from HREC for the lead site, Emeritus Research, Camberwell, VIC for the Phase 2, Blinded, Placebo Controlled Clinical Trial to Determine the Effect on Pain...
Autoinjectors Market to Grow at 16.2% CAGR and Reach USD 3.8 Bn by 2031 | Excusive Research by Transparency Market Research
June 15, 2023 10:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, June 15, 2023 (GLOBE NEWSWIRE) -- The global autoinjectors market was valued at USD 1.0 Bn in 2022 and is projected to grow at a CAGR of 16.2% from 2023 to 2031....
Incannex Company Presentation – Results from Phase 1 Clinical Trial to Assess Proprietary IHL-675A
May 03, 2023 07:30 ET
|
Incannex Healthcare
MELBOURNE, Australia, May 03, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ or ‘the Company’) is pleased to announce a company presentation containing data...
Global Rheumatoid Arthritis Diagnosis Tests Strategic Business Report 2023: Repercussions of Sub Optimal Accuracy in RA Testing Drive the Need for Multiple Tests
April 10, 2023 09:48 ET
|
Research and Markets
Dublin, April 10, 2023 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis Diagnosis Tests: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
Global Rheumatoid Arthritis Market Size To Grow USD 6.9 Billion By 2030 | CAGR of 3.2%
March 15, 2023 12:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , March 15, 2023 (GLOBE NEWSWIRE) -- The Global Rheumatoid Arthritis Market Size to grow from USD 6.1 billion in 2021 to USD 6.9 billion by 2030, at a Compound Annual Growth...
The Arthritis Therapeutics Market Is Estimated To Grow 1.5x During By 2027: Fact.MR Analysis
March 06, 2023 14:00 ET
|
FACT.MR
Rockville , March 06, 2023 (GLOBE NEWSWIRE) -- The global arthritis therapeutics market would expand 1.5 times from 2020 to 2027. Patients in Europe and North America would push demand for...
[Trending] Global Rheumatoid Arthritis Drugs Market Size & Share to Hit $ 70.1 Billion by 2030 at a 1.75% CAGR: Growing cases of rheumatoid arthritis to propel market demand- Facts & Factors
February 10, 2023 04:10 ET
|
Facts & Factors
SAN FRANCISCO, U.S., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Rheumatoid Arthritis Drugs Market Size, Share, Growth Analysis Report By...